Renaissance Capital logo

4 US IPOs planned for the week of Sep 24

September 24, 2012

The following IPOs are expected to price this week:

Grupo Financiero Santander Mexico (BSMX), a second largest bank in Mexico and a spin-off of Spanish bank Santander, plans to raise $2.8 billion by offering 235.1 million shares at a price range of $10.99 to $12.70. At the midpoint of the proposed range, Grupo Financiero Santander Mexico would command a market value of $16.1 billion. Grupo Financiero Santander Mexico, which was founded in 1991, booked $3.2 billion in sales over the last 12 months. The Colonia Lomas de Santa Fe, Mexico-based company plans to list on the NYSE under the symbol BSMX. Santander, UBS Investment Bank, Deutsche Bank and BofA Merrill Lynch are the joint bookrunners on the deal.Please note: Filed under Santander Mexico Financial Group.

GlobeImmune
(GBIM), which is developing therapeutic drugs for pancreatic cancer and hepatitis B and C, plans to raise $60 million by offering 5.0 million shares at a price range of $11.00 to $13.00. At the midpoint of the proposed range, GlobeImmune would command a market value of $207 million. GlobeImmune, which was founded in 1995, booked $9 million in sales over the last 12 months. The Louisville, CO-based company plans to list on the NASDAQ under the symbol GBIM. Wells Fargo Securities and Piper Jaffray are the joint bookrunners on the deal.

Qualys (QLYS), which provides cloud-based IT security and compliance software solutions, plans to raise $91 million by offering 7.6 million shares at a price range of $11.00 to $13.00. At the midpoint of the proposed range, Qualys would command a market value of $414 million. Qualys, which was founded in 1999, booked $83 million in sales over the last 12 months. The Redwood Shores, CA-based company plans to list on the NASDAQ under the symbol QLYS. J.P. Morgan and Credit Suisse are the joint bookrunners on the deal.

Summit Midstream Partners (SMLP), which owns natural gas gathering systems and pipelines, plans to raise $250 million by offering 12.5 million shares at a price range of $19.00 to $21.00. At the midpoint of the proposed range, Summit Midstream Partners would command a market value of $996 million. Summit Midstream Partners, which was founded in 2009, booked $138 million in sales over the last 12 months. The Dallas, TX-based company plans to list on the NYSE under the symbol SMLP. Barclays, BofA Merrill Lynch, Goldman Sachs and Morgan Stanley are the joint bookrunners on the deal.

Renaissance Capital will have Pre-IPO Research available on each of these upcoming IPOs prior to its pricing.

Last week, there were 5 IPO pricings. Trulia (TRLA), a online residential real estate marketplace with 22 million monthly unique visitors, was the week's winner, ending up 35% from its IPO price.